
    
      In clinical institutions that enroll corona virus disease 2019 patients whose nucleic acids
      changed from negative to positive, two arms, multi-center, randomized and controlled methods
      are adopted. Patients are divided into two groups, favipiravir group and regular treatment
      group. 210 patients are expected to be enrolled and the cases are allocated according to the
      ratio of 2( favipiravir group): 1(regular treatment group).
    
  